Expression of renal 11β-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function

被引:40
|
作者
Quinkler, M
Zehnder, D
Lepenies, J
Petrelli, MD
Moore, JS
Hughes, SV
Cockwell, P
Hewison, M
Stewart, PM [1 ]
机构
[1] Univ Birmingham, Sch Med, Div Med Sci, Queen Elizabeth Hosp, Birmingham B15 2TT, W Midlands, England
[2] Univ Birmingham, Sch Med, Dept Nephrol, Queen Elizabeth Hosp, Birmingham B15 2TT, W Midlands, England
[3] Charite Univ Med Belin, Div Clin Endocrinol, Berlin, Germany
关键词
D O I
10.1530/eje.1.01954
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Renal 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta-HSD2) enables selective access of aldosterone to the mineralocorticoid receptor (MR). Impaired 11 beta-HSD2 activity has been suggested in patients with hypertension as well as in patients with renal disease, where it may contribute to sodium retention, oedema and hypertension. To date, these studies have relied upon urinary cortisol (F) metabolite levels as surrogate markers of renal 11 beta-HSU2 activity. Methods: We have directly analysed renal 11 beta-HSD2 mRNA expression in 95 patients undergoing kidney biopsy using TaqMan real-time PCR. Serum and 24-h urine samples were used to document underlying renal function and endocrine parameters. Urinary F and cortisone (E) metabolites were analysed using gas chromatography/mass spectrometry. Results: Expression of 11 beta-HSD2 did not correlate with blood pressure or urinary Na/K ratio, but a significant positive correlation with creatinine clearance was observed (r = 0.284; P < 0.01). Immunofluorescence and confocal laser microscopy confirmed decreased 11 beta-HSD2 expression in patients with impaired renal function. For the first time, we showed that 11 beta-HSD2 mRNA expression correlated negatively with the urinary free (UF) F/E (UFF/UFE) ratio (r = 0.276; P < 0.05) as well as with the urinary tetrahydrocortisol + 5 alpha-tetrahydrocortisol/tetrahydrocortisone ((THF + alpha THF)/THE) ratio (r = 0.256; P < 0.05). No difference in 11 beta-HSD2 mRNA expression or in the UFF/UFE ratio was found between groups with no proteinuria, microalbummuria, moderate or severe proteinuria. In contrast, the urinary (THF + alpha THF)/THE ratio increased significantly (P < 0.05) in patients with severe albuminuria, suggesting increased hepatic 11 beta-HSD1 in those patients. Conclusions: These data suggest that renal 11 beta-HSD2 expression may be represented only marginally better, if at all, by the UFF/UFE than by the (THF + alpha THF)/THE ratio. Reduced renal 11 beta-HSD2 expression may lead to occupancy of the MR by glucocorticoids such as cortisol and may contribute to the increased sodium retention seen in patients with impaired renal function.
引用
收藏
页码:291 / 299
页数:9
相关论文
共 50 条
  • [31] Structural analysis of the 11β-hydroxysteroid dehydrogenase type 2 gene in end-stage renal disease
    Zaehner, T
    Plueshke, V
    Frey, BM
    Frey, FJ
    Ferrari, P
    KIDNEY INTERNATIONAL, 2000, 58 (04) : 1413 - 1419
  • [32] Role of 11β-hydroxysteroid dehydrogenase 2 renal activity in potassium homeostasis in rats with chronic renal failure
    Yeyati, N. L.
    Altuna, M. E.
    Damasco, M. C.
    Mac Laughlin, M. A.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2010, 43 (01) : 52 - 56
  • [33] Myometrial expression of 11β-hydroxysteroid dehydrogenase type 2 in rat pregnancy
    Burton, PJ
    Waddell, BJ
    JOURNAL OF ENDOCRINOLOGY, 2002, 172 (03) : 519 - 526
  • [34] Cloning and expression of the bovine 11β-hydroxysteroid dehydrogenase type-2
    Romero, DG
    Zhou, MY
    Gomez-Sanchez, CE
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2000, 72 (05): : 231 - 237
  • [35] Expression of 11β-hydroxysteroid dehydrogenase type 2 is deregulated in colon carcinoma
    Moravec, Martin
    Svec, Jiri
    Ergang, Peter
    Mandys, Vaclav
    Rehakova, Lenka
    Zadorova, Zdena
    Hajer, Jan
    Kment, Milan
    Pacha, Jiri
    HISTOLOGY AND HISTOPATHOLOGY, 2014, 29 (04) : 489 - 496
  • [36] Increased apical targeting of renal epithelial sodium channel subunits and decreased expression of type 2 11β-hydroxysteroid dehydrogenase in rats with CCl4-induced decompensated liver cirrhosis
    Kim, SW
    Schou, UK
    Peters, CD
    de Seigneux, S
    Kwon, TH
    Knepper, MA
    Jonassen, TEN
    Frokiaer, J
    Nielsen, S
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (11): : 3196 - 3210
  • [37] Renal medullary 11β-hydroxysteroid dehydrogenase type 1 in Dahl salt-sensitive hypertension
    Liu, Yong
    Wi, Milwaukee
    Singh, Ravinder J.
    Usa, Kristie
    Netzel, Brian C.
    Liang, Mingyu
    HYPERTENSION, 2008, 52 (04) : E55 - E55
  • [38] Renal medullary 11β-hydroxysteroid dehydrogenase type 1 in Dahl salt-sensitive hypertension
    Liu, Yong
    Singh, Ravinder J.
    Usa, Kristie
    Netzel, Brian C.
    Liang, Mingyu
    PHYSIOLOGICAL GENOMICS, 2008, 36 (01) : 52 - 58
  • [39] Increased expression of 11β-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes
    Abdallah, BM
    Beck-Nielsen, H
    Gaster, M
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (10) : 627 - 634
  • [40] Progressive 11β-Hydroxysteroid Dehydrogenase Type 2 Insufficiency as Kidney Function Declines
    Uslar, Thomas
    Newman, Andrew J.
    Tapia-Castillo, Alejandra
    Carvajal, Cristian A.
    Fardella, Carlos E.
    Allende, Fidel
    Solari, Sandra
    Tsai, Laura C.
    Milks, Julia
    Cherney, Michael
    Stouffer, David G.
    Auchus, Richard
    Brown, Jenifer M.
    Baudrand, Rene
    Vaidya, Anand
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,